Introduction {#sec1-1}
============

Hysterosalpingography (HSG) is an X-ray diagnostic procedure for imaging of the uterus and fallopian tubes. Its applications consist of diagnosing causes of infertility in females, showing areas of scarring inside a fallopian tube or changing in the uterine cavity, evaluating patients who have had several miscarriages, investigating patients prior to myomectomy, diagnosing cervico-uterus anomalies and locating intrauterine device that cannot be seen on a pelvic examination \[ [@ref1] - [@ref3] \].

The topmost indication for HSG investigations is infertility \[ [@ref4] , [@ref5] \]. Worldwide, 15% of reproductive-aged couples are affected by infertility. While in Sub-Sahara Africa more than 30% of women between the ages of 25 and 49 suffer from secondary infertility \[ [@ref6] , [@ref7] \]. Secondary infertility has also been reported in Nigeria \[ [@ref8] , [@ref9] \]. Patients recommended for HSG are under pressure to alleviate the burden and stigma of infertility that they care less about the side effects of their examination. Even, large percent of these patients and some referring physicians are ignorant of risks associated with radiation dose. Ignorance of patients and physicians on the health implications of medical radiation examination has been reported \[ [@ref10] , [@ref11] \].

During HSG examinations, X-ray beam is focused on the female genital tract thus irradiation of this organ is inevitable in the process. The uterus and ovaries are known to receive the highest dose as the pelvis is irritated. \[ [@ref5] , [@ref12] \]. Involved organ must have the minimum exposure to radiation. Above all, several radiographs are taken in order to visualize different views. The cumulative dose from these exposures may result in the high dose to the region of interest, thereby leading to cancer induction or birth defect. According to literature, most patients recommended for HSG desire pregnancy \[ [@ref4] , [@ref13] , [@ref14] \]. As such, optimization of dose and image quality are essential. Though, hysterosalpingography has been considered as a low-risk examination yet, several factors can cause the patient to receive high dose radiation. Variation in protocol from one healthcare institution to another one has been reported \[ [@ref14] \]. These variations result from limited understanding of procedures, state of available resources and multiple exposures among others. Such lapses can lead to increasing radiation dose to patients.

Hysterosalpingography is supposedly a fluoroscopic procedure and conducted using fluoroscopy facility. Modern fluoroscopic units have incorporated additional features minimizing radiation exposure \[ [@ref14] \]. However, some study centers employed conventional radiography machine for this purpose. In centers, where fluoroscopic equipment is available, the machines are old and cannot deliver the desired quality outcome. Technical errors and optimization of procedures will be unavoidable and faulted, respectively, thereby, leading to unnecessary irradiation of patients. The use of conventional X-ray machine and analogue fluoroscopy equipment for hysterosalpingography have been reported to deliver high radiation dose to the region of interest as compared to the digital fluoroscopy unit \[ [@ref4] , [@ref14] \]. If the exposure takes longer time, the dose will be received more by patients. According to \[ [@ref15] \], exposure time for normal hysterosalpingography and abnormal procedure is about 54 and 100 seconds on the average, respectively. The fluoroscopy procedure resulted in an entrance surface dose (ESD) of about 11 mGy. However, study by \[ [@ref14] \] using C-arm reported mean exposure time as 4.2 and 14.3 seconds for normal HSG and abnormal procedure, respectively. They estimated the mean ESD as 2.6 ±9.8 mGy and 6.9 ±10.7 mGy for normal procedure and abnormal procedure, respectively. This implies that the use of conventional radiography machine for HSG is prolonged and delivers higher dose than fluoroscopy equipment. This correlation was observed in the study by Sulieman et al. who noted that hysterosalpingography with fluoroscopic technique reduces patient dose by a factor of 3 \[ [@ref16] \].

Research by \[ [@ref12] \] recorded a dose of 4.5 mGy and 6.2 mGy for ovaries and uterus, respectively, during assessment of hysterosalpingography in Italy. A study by \[ [@ref17] \] reported radiation dose of 2.7 mGy for female gonad with effective dose of 1.2 mSv. A similar study conducted to evaluate patient absorbed dose during HSG in Nigerian hospital recorded a mean value of 5.87 ± 4.56 with a range of 0.02 to 13.08 mGy \[ [@ref13] \]. Research carried out by \[ [@ref4] \] in order to investigate patient dosimetry in hysterosalpingography estimated the mean entrance surface dose to be 14.6 mGy. Similar investigation in Sudan reported mean entrance surface dose to be 20.9 mGy \[ [@ref5] \]. Complications arising from the irradiation of female pelvis have been reported in the literature. Some defects were noted, including ovarian failure, uterus impairment, premature labour, miscarriages among others \[ [@ref18] , [@ref19] \]. Though the dose due to HSG is relatively low, the tendency for the incidence of cancer induction cannot be overruled.

The goal of this study is to investigate effective dose to patient during hysterosalpingography procedure in order to enhance the optimization of dose and minimize the associated radiation risks. Also to generate baseline data that can be used to benchmark good practice for future research in the study region.

Material and Methods {#sec1-2}
====================

The prospective pilot study, was conducted in 4 selected tertiary healthcare institutions in southwest Nigeria designated as SW1, SW2, SW3 and SW4, respectively. The quality control of the X-ray machines was conducted using MagicMax quality control kits (IBA Dosimetry, Germany). A total of 80 patients were examined for a period of six months with 20 patients from each center. Informed consent was obtained from each patient before the commencement of the examination. Institutional consent was obtained from each hospital used and also the Nigerian Institute of Medical Research (NIMR). Radiation dose measurements were made for patients during HSG procedure using thermoluminiscence dosimeters (TLD-100: LiF: Mg, Ti). The TLD chips were obtained from RadPro International GmbH, Germany. The chips were oven-annealed using Carbolite oven made in England. Irradiation of chips was conducted at the Secondary Standard Dosimetry Laboratory (SSDL) of the National Institute of Radiation Protection and Research (NIRPR), Ibadan. Calibration of TLD chips and reader were conducted and TLD chips were read using Harshaw Reader (Model 3500) at the Department of Physics, Obafemi Awolowo university Ile-Ife. Each of the TLDS was enclosed in labelled black polythene pack. A total of three coded chips were used to measure the entrance surface dose (ESD) during each procedure in order to obtain the mean and enhance precision. The chips were attached to an elastic tape and placed in the center of X-rays field where the beam was intercepted by the irradiated part of the patient. These chips were made to remain fixed on the patient throughout the entire procedure.

Patient's clinical information and exposure parameters were noted and recorded using self-structured form. PCXMC software (version 20 Rotation) was used to evaluate the effective and organ doses. Statistical analysis of data was carried out using SPSS (Version 23) and Microsoft excel.

Results {#sec1-3}
=======

Specifications of machine used for investigation are presented in [Table 1](#T1){ref-type="table"}. Analysis of radiation doses, exposure parameters and patients' parameters in each study center are as shown in [Table 2](#T2){ref-type="table"}. The result obtained showed that infertility (58%) is the major cause for HSG examinations in the study centers as depicted in [Figure 1](#JBPE-10-131-g001.tif){ref-type="fig"}. Sample of 5 anatomical views of HSG in one of the study centers is as shown in [Figure 2](#JBPE-10-131-g002.tif){ref-type="fig"}. The means entrance surface dose (ESD) obtained from the four centers were 18.58±6.31 mGy, 15.18±2.27 mGy, 17.44±3.43 mGy and 34.24±11.98 mGy for SW1, SW2, SW3 and SW4 centers, respectively. The corresponding mean effective doses were 1.54±0.63 mSv, 1.24±0.28 mSv, 1.41±0.30 mSv and 2.53±0.94 mSv for SW1, SW2, SW3 and SW4 centers, respectively as shown in [Figure 3](#JBPE-10-131-g003.tif){ref-type="fig"}. The doses of ovary, uterus and urinary bladder are 3.51 mGy, 4.35 mGy and 8.98 mGy for SW1, respectively, 2.81 mGy, 3.49 mGy and 7.23 mGy for SW2, respectively, 2.96 mGy, 3.87 mGy and 8.31 mGy for SW3, respectively, and 5.54 mGy, 6.95 mGy, and 14.68 mGy for SW4, respectively, as shown in [Figures 4](#JBPE-10-131-g004.tif){ref-type="fig"}. Correlation plots between the measured entrance surface dose (ESD) and exposure parameters are presented in [Figure 5](#JBPE-10-131-g005.tif){ref-type="fig"}. [Figure 6](#JBPE-10-131-g006.tif){ref-type="fig"} compares the results obtained in this study with similar studies in literature.

###### 

Specification of machine used for hysterosalpingography in the study centers.

  Machine Parameters    Names of diagnostic centers                              
  --------------------- ----------------------------- -------------- ----------- --------------
  Name of Machine       Toshiba                       GE             Allengers   GE
  Type of Machine       Computed                      Conventional   Computed    Conventional
  Year of Manufacture   2011                          2007           2014        2010
  Filtration (mmAl)     0.90                          1.60           0.90        0.83

###### 

Analysis of variance

                  N        Mean     Std. Deviation   Minimum   Maximum
  --------- ----- -------- -------- ---------------- --------- ---------
  **ESD**   SW1   20       18.58    6.31             10.33     31.07
  SW2       20    15.18    2.27     10.94            18.61     
  SW3       20    17.44    3.43     11.45            21.99     
  SW4       20    34.24    11.98    20.04            61.22     
  Total     80    21.36    10.28    10.33            61.22     
  **kVp**   SW1   20       92.10    5.71             84.00     100.00
  SW2       20    74.70    3.40     70.00            78.00     
  SW3       20    91.65    6.82     82.00            105.00    
  SW4       20    87.25    3.80     80.00            90.00     
  Total     80    86.43    8.68     70.00            105.00    
  **mAs**   SW1   20       26.20    2.59             24.00     30.00
  SW2       20    26.80    4.74     20.00            32.00     
  SW3       20    34.50    15.97    25.00            75.00     
  SW4       20    82.10    20.01    64.00            125.00    
  Total     80    42.40    26.60    20.00            125.00    
  **FDD**   SW1   20       100.75   5.91             90.00     110.00
  SW2       20    103.50   4.89     100.00           115.00    
  SW3       20    100.75   5.91     90.00            110.00    
  SW4       20    96.00    13.73    70.00            110.00    
  Total     80    100.25   8.67     70.00            115.00    
  **FSD**   SW1   20       71.75    2.88             65.00     75.00
  SW2       20    78.05    4.08     72.00            89.00     
  SW3       20    74.15    4.37     68.00            83.00     
  SW4       20    70.25    13.04    41.00            88.00     
  Total     80    73.55    7.76     41.00            89.00     
  **BMI**   SW1   20       26.58    3.19             21.48     34.77
  SW2       20    23.64    2.38     19.92            28.13     
  SW3       20    25.59    2.89     19.14            30.08     
  SW4       20    26.31    2.62     21.88            31.25     
  Total     80    25.53    2.97     19.14            34.77     
  **Age**   SW1   20       35.90    4.81             27.00     49.00
  SW2       20    36.00    3.32     30.00            41.00     
  SW3       20    34.35    3.13     28.00            40.00     
  SW4       20    33.70    3.28     29.00            39.00     
  Total     80    34.99    3.76     27.00            49.00     

ESD = entrance surface dose, kVp = Kilovoltage peak, mAs = current time product, FDD = focus detector distance, FSD = focus skin distance, BMI = Body mass index
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![Comparison of (a) entrance surface dose (ESD) and effective dose (E) (b) exposure parameters (c) organ dose with other authors](JBPE-10-131-g006){#JBPE-10-131-g006.tif}

Discussion {#sec1-4}
==========

Several studies have been conducted on hysterosalpingography (HSG) in different parts of the world \[ [@ref2] , [@ref3] , [@ref8] \]. To the best of our knowledge, no study has been conducted on radiation dose measurement during the procedures in Southwest, Nigeria. The work of Okeji et al. was conducted in Southeast Nigeria and so far the only one reported in literature with regards to radiation dose measurement \[ [@ref13] \]. The world over, few studies have been published regarding the radiation doses received by patients during HSG. Similar observation has been noted by other authors \[ [@ref4] , [@ref20] \]. HSG examinations are often conducted due to infertility \[ [@ref8] , [@ref21] \]. Same one was observed in this study. The prevalence of infertility in Sub-Sahara Africa is widely reported \[ [@ref6] , [@ref7] \]. It is essential that radiation dose absorbed by patients during the procedure is monitored in order to minimize the risks to irradiated reproductive organs.

Imaging modalities have been noted to deliver to patients in a wide range of doses \[ [@ref20] , [@ref22] - [@ref27] \]. Same trend has been observed in this study; there is a large variation in the entrance surface dose (ESD) within the same hospital and from one center to others ([Table 2](#T2){ref-type="table"}). The disparity between the minimum and maximum ESD in the study centers is in the ratio 1:3.0, 1:1.7, 1:1.9 and 1:3.1 for SW1, SW2, SW3 and SW4, respectively. The large variations within the same hospital are traceable to inconsistency in the selection of exposure parameters, inadequate quality control measures, and lack of uniform protocol and multi-tasking of imaging system among others. Variation between hospitals can be linked to the usage of different equipment ([Table 1](#T1){ref-type="table"}) and lack of guidance level for references.

However, the mean entrance surface dose (ESD) in this study is comparable except for center SW4. This implies dose harmonization is possible from one hospital to another one. The high dose recorded in center SW4 was due to the type of imaging system and inadequate quality control measures. The conventional radiography machine used in the center is the capacitive type. The mechanism of the equipment sometimes warranted taking repeated exposure that consequently increased the ESD. Another paramount factor is the high tube current used. There was strong correlation between the ESD and mAs as shown in [Figure 5d](#JBPE-10-131-g005.tif){ref-type="fig"}. ESD is proportional to the tube current and boosts as tube current increase \[ [@ref20] , [@ref22] \].

The lower ESD values reported for SW1 and SW3 center are attributable to the use of computed radiography. Digital systems are known to deliver lower dose as compared to conventional radiography \[ [@ref4] , [@ref14] \]. In addition, the centers dedicated an X-ray machine specifically for fluoroscopic procedures. Such decision enhances the efficiency of machine and consequently the machine output. Center SW2 has the least range and the lowest mean ESD. Lower ESD values recorded is traceable to the correct use of exposure parameters. The center uses lower kVp and mAs values while the FFD was higher as compared to other centers. This is indicative of adherence to ALARA (as low as reasonably achievable) principle and skillful personnel in the center. Furthermore, the participants in this center have had lower body mass index (BMI) in general. Since tube voltage is chosen according to patient BMI, invariably low BMI will culminate in low dose. The influence of exposure parameters on ESD is paramount as a little shift in every parameter has a significant impact on the patient absorbed dose ([Figure 5](#JBPE-10-131-g005.tif){ref-type="fig"}). It is on this basis the radiation regulatory authorities demand optimization of procedure.

Effective dose (ED) is a measure of radiation risk. The mean effective dose in the centers ranged from 1.24 mSv in center SW2 to 2.53 mSv in center SW4. Since effective dose is evaluated by ESD, its value will follow the same trend as ESD values in the study centers. Same trend follows for the evaluated organ doses (ovary, uterus, urinary bladder) as shown in [Figure 4](#JBPE-10-131-g004.tif){ref-type="fig"}. Center SW2 has the least doses given by 2.81 mGy, 3.49 mGy and 7.23 mGy for ovary, uterus and urinary bladder doses, respectively. Centre SW4 has the highest values given by 5.54 mGy,6.95 mGy and 14.68 mGy in the same order. In all the centers, urinary bladder doses were higher than ovary and uterus doses. Similar results have been noted by other authors \[ [@ref5] , [@ref28] \]. This is due to the position of the bladder with respect to the irradiated organ.

The range of ESD values reported in this study is comparable with many results reported in literature ([Figure 6a](#JBPE-10-131-g006.tif){ref-type="fig"}). Though the cumulative mean ESD value (21.36 mGy) is higher than some previous studies, this can be attributed to the result from center SW4. Moreover, the tube voltage used in this study is somewhat higher than that used by other authors. The study of \[ [@ref20] \] recorded a higher dose with lower tube voltage to the present study. The type of TLD used by the authors might be responsible for this anomaly. For \[ [@ref12] \], the tube voltage was not reported, but the ESD value was higher than that from this study. The mean ESD value obtained by \[ [@ref5] \] is in close approximation with present study. This confirms the possibility of dose harmonization. Although it has been reported that doses from fluoroscopy procedures can vary as much as ten times for the same fluoroscopy time \[ [@ref29] \]. The method employed in the determination of ESD by various authors, the choice of exposure parameters, the specificity of imaging equipment among others are some of the significant factors responsible for patient dose variability.

Cumulative effective dose from this study is also comparable with previous studies ([Figure 6a](#JBPE-10-131-g006.tif){ref-type="fig"}). The contrast in some values is due to various software and formulae used to estimate effective dose by various authors. United Nations Scientific Committee on the Effects of Atomic Radiation \[ [@ref30] \] gave a value of 1.2 mSv for effective dose arising from hysterosalpingography. This value is for single author. It is important that doses from several authors are harvested to enable the development of guidance level, thereby minimizing patient dose. Similarly, the organ doses from this study are comparable with other studies ([Figure 6c](#JBPE-10-131-g006.tif){ref-type="fig"}). The disparity noted is attributable to tools of estimation used by other authors. Above all, parameters influencing the ESD value reported in this study are also contributing factors responsible for the variation in effective and organ doses. Previous authors did not report doses to the urinary bladder, except for \[ [@ref5] , [@ref28] \]. This explains why the value was not in [Figure 6c](#JBPE-10-131-g006.tif){ref-type="fig"}. Radiation doses during hysterosalpingography cannot be overlooked irrespective of the dose value because cancer induction has no threshold. More so, reproductive organs aspiring for fertility are being irradiated and these organs are highly sensitive to radiation. It is therefore essential that periodic dose audit be conducted for optimization.

Conclusion {#sec1-5}
==========

The measurement of radiation dose during hysterosalpingography was investigated using thermoluminescence dosimeters. The dose indices evaluated were relatively high but comparable to previous studies. Significant factors that influenced doses in the study centers consist of the quality and usage of imaging equipment, exposure parameters, the level of skill expertise and adherence to ALARA principle. Results of our study revealed the possibility of dose harmonization between hospitals with variant equipment and protocol. The authors recommend comprehensive clinical audit in centers with high doses.
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